Tag: Zydus
Zydus Takeda Healthcare marks 25 years of manufacturing operations in India
Both partners Zydus and Takeda to make the JV Company, Zydus Takeda Healthcare Private Limited’s (ZTHPL) plant at Vashi, a strategic site to support Takeda’s new products.
Padma Bhushan bestowed on Pankaj Patel: Zydus Chairman calls himself fortunate,...
Under his leadership, Zydus continues to innovate, aiming to provide affordable healthcare solutions worldwide
Zydus Lifesciences receives approval from USFDA to conduct Phase II(b) clinical...
Usnoflast is a novel oral NLRP3 inflammasome inhibitor in patients with Amyotrophic Lateral Sclerosis (ALS)
Sterling Biotech to start world’s first precision fermentation-based dairy protein factory...
Spanning 27 acres, this state-of-the-art facility is expected to be operational by the first quarter of 2026
WHO prequalifies Zydus’s Typhoid Vi Conjugate Vaccine, ZyVac® TCV
Company receives acceptability, in principle, for ZyVac® TCV making it eligible for purchase by United Nations procurement agencies
Burkert inaugurates new manufacturing facility in Pune to strengthen its portfolio...
This state-of-the-art facility is a significant addition to Burkert’s global value chain, aimed at meeting the growing demand in the region by producing components and system solutions
CSIR-CDRI Lucknow and Zydus to develop best-in-class drug for CKD induced...
Under this agreement, CDRI and Zydus will jointly undertake preclinical research. Any drug candidate emerging from the efforts will be developed by Zydus for India and other markets
Zydus to acquire 50% stake in Sterling Biotech to enter into...
Post this transaction, Sterling Biotech will become a 50:50 Joint Venture with equal representation on the Board
Zydus secures Mexico’s COFEPRIS approval for its biosimilar ‘Bhava’ to treat...
Zydus Lifesciences receives approval to market Bhava™ for various cancers in Mexico, expanding access to affordable oncology treatments
Sentynl Therapeutics, a Zydus Group company announces global acquisition of Zokinvy
Zokinvy is approved in the US, European Union and Great Britain, and Japan for the treatment of Progeria, a collection of ultra-rare, fatal, genetic premature aging diseases that accelerate mortality in young patients